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The diverse repertoire of T-cell receptors (TCR) plays a key role in the adaptive immune response
to infections. Previous studies show that secondary responses to the yellow fever vaccine — the model
for acute infection in humans — are weaker than primary ones, but only quantitative measurements
can describe the concentration changes and lineage fates for distinct T-cell clones in vivo over time.
Using TCR alpha and beta repertoire sequencing for T-cell subsets, as well as single-cell RNAseq
and TCRseq, we track the concentrations and phenotypes of individual T-cell clones in response
to primary and secondary yellow fever immunization showing their large diversity. We confirm the
secondary response is an order of magnitude weaker, albeit ∼ 10 days faster than the primary one.
Estimating the fraction of the T-cell response directed against the single immunodominant epitope,
we identify the sequence features of TCRs that define the high precursor frequency of the two major
TCR motifs specific for this particular epitope. We also show the consistency of clonal expansion
dynamics between bulk alpha and beta repertoires, using a new methodology to reconstruct alpha-
beta pairings from clonal trajectories.
INTRODUCTION
T-cells play a crucial role in the immune response to
pathogens by mediating antibody formation and clear-
ance of infected cells, and by defining an overall response
strategy. The specificity of T-cells is determined by the
T-cell receptor (TCR), a heterodimer of alpha and beta
protein chains. Genes for alpha and beta chains assem-
ble in a random process of somatic V(D)J-recombination,
which leads to a huge variety of possible TCRs [1]. The
resulting diverse na¨ıve repertoire contains T-cell clones
that recognize epitopes of yet unseen pathogens, and can
participate in the immune response to infection or vac-
cination. One of the best established models of acute
viral infection in humans is yellow fever (YF) vaccina-
tion. Yellow fever vaccine is a live attenuated virus with
a peak of viremia happening around day 7 after vaccine
administration [2–4]. The dynamics of primary T-cell
response was investigated by various techniques: cell ac-
tivation marker staining [2, 5–7], MHC multimer stain-
ing [3, 5, 7, 8], high-throughput sequencing [9, 10] and
deuterium cell labelling [11]. Primary T-cell response
sharply peaks around 2 weeks after YFV17D (vaccine
strain of yellow fever virus) vaccination [2, 3, 6, 8, 10].
The immune response is very diverse and targets mul-
tiple epitopes inside the YF virus [3, 5, 8, 12, 13]. An
essential feature of effective vaccination is the formation
of immune memory. Although most of the effector cells
die shortly after viral clearance, YF-specific T-cells could
be found in the blood of vaccinated individuals years
[3, 7, 8, 11] and even decades after vaccination [14, 15].
While the immune response to the primary vaccination
has been much studied, there is only limited data on the
response to the booster vaccination with YFV17D. Both
T-cell activation marker staining and multimer staining
show that the secondary response is much weaker than
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2the primary one [7], but their precise dynamics, diversity,
and clonal structure are still unknown.
In summary, previous studies provide insight into the
macroscopic features of the T-cell response, such as to-
tal frequency of T-cells with an activated phenotype, or
T-cells specific to a particular viral epitope on different
timepoints after vaccination. However, with recently de-
veloped methods it is now possible to uncover the micro-
scopic structure of the primary and secondary immune
response, such as the dynamics and phenotypes of dis-
tinct T-cell clones, as well as the receptor features that
determine the recognition of epitopes.
TCR repertoire sequencing allows for longitudinally
tracking individual clones of responding T-cells irrespec-
tive of their epitope specificity. Single-cell RNAseq (scR-
NAseq) enables simultaneous quantification of thousands
of transcripts per cell for thousands of cells, providing
an unbiased characterization of immune cell phenotype.
Single-cell TCR sequencing produces paired αβ reper-
toire data, and thus could help discover conserved se-
quence motifs in one or both TCR chains. These mo-
tifs encode TCR structural features essential to antigen
recognition [16, 17]. Information about complete TCR
sequences allows homological modeling of TCR struc-
ture [18], which can be used for binding prediction with
protein-protein docking [19]. We combine longitudinal
TCR alpha and beta repertoire sequencing, scRNAseq,
scTCRseq, TCR structure modelling and TCR-pMHC
docking simulations to get a comprehensive picture of pri-
mary and secondary T-cell response to the yellow fever
vaccine – the in vivo model of acute viral infection in
humans.
RESULTS
Secondary T-cell response to the YFV17D vaccine is
weaker but faster than the primary response
We sequenced TCR alpha and TCR beta repertoires
of bulk peripheral blood mononuclear cells (PBMCs)
and different T-cell subsets at multiple timepoints before
and after primary and booster vaccination against yellow
fever of donor M1 (Fig. 1A). Clonotypes responding to
the primary YF immunization were identified using the
edgeR software as previously described [10]. Briefly, the
biological replicates of bulk PBMCs were used to esti-
mate the noise in the TCR mRNA counts. Clonotypes
were assumed YF-responding if they increased in con-
centration more than 32-fold (p < 0.01) between any two
timepoints before the peak of the primary response (days
0, 5, 10 and 15).
Overall we found 1580 TCR beta and 1566 TCR alpha
clonotypes significantly expanded after the primary im-
munization, respectively occupying 6.7% and 7.8% of the
sampled TCR repertoire in cumulative frequency at the
peak of the response (Fig. 1B, C). As expected, both the
numbers of responding clones and their cumulative fre-
quencies were very similar for expanded clonotypes iden-
tified in bulk TCR alpha and beta repertoires. For sim-
plicity in the following sections we focus on TCR beta
repertoires, unless stated otherwise. In accordance with
previous studies [2, 3, 5, 7, 10], we show that during the
primary response T-cells expanded intensely (with cumu-
lative increase of about 950-fold) within 2-3 weeks after
YF immunization. They subsequently contracted, but
still exceeded baseline frequency 18 months afterwards.
We then tracked these YF-responding clonotypes iden-
tified during primary immunization before and after the
second vaccination 18 months after the first one. The
cumulative frequency of these clonotypes increased ≈2.5-
fold at the peak of the response after the second immu-
nization, reaching 0.5% of the TCR repertoire (Fig. 1D,
blue curve). The secondary response was weaker, but
happened much faster than the primary one, with a peak
frequency of responding clonotypes occurring on day 5
instead of day 15 after vaccination.
Using sequenced CD4+ and CD8+ T-cell subsets, we
attributed a CD4 or CD8 phenotype to each respond-
ing clone (see Methods) and thus could track these two
subsets separately. After booster immunization in donor
M1, YF-responding CD4+ cells peaked earlier (day 5 vs
day 10) and expanded much more (≈ 8 times vs. ≈ 1.5
times) than CD8+ T-cells (Fig. 1D, green and pink
curves). During primary immunization, the difference
in response dynamics between CD4+ and CD8+ sub-
sets was less prominent, as they both peaked on day 15.
However, by day 21 CD4+ responding clones contracted
much more (to 43.6% of peak frequency) than CD8+
clonotypes (87% of peak frequency). These observations
confirm previous reports that the CD4 response precedes
the CD8 response [5].
Secondary response to booster vaccination after 18
months and after 30 years have similar features
To see how long-lived T-cell memory response to YF
can be, we recruited an additional donor (P30), who re-
ceived the first YF-vaccine 30 years earlier and has not
been in YF endemic areas for at least 28 years. From
this donor, we collected bulk PBMCs and several T-cell
subsets before and after booster immunization. Both the
numbers of responding clonotypes (204 for TCR beta and
201 for TCR alpha) and the maximum frequency at the
peak of the response (0.69%) were much lower than for
any primary vaccinee both from this and other studies
(Fig. S1). Most of these clonotypes were low frequency
or undetected before the second immunization, although
a few were sampled in the memory repertoire prior to
vaccination.
The response to the booster vaccination was charac-
terized by a large expansion between days 0 and 5, and a
peak on day 10, for both CD4+ and CD8+ T-cells. Over-
all the dynamics and the magnitude of this response was
very similar to the response to the booster vaccination
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FIG. 1. Primary and secondary response to yellow fever vaccination. A. Experiment design. Blood was taken at
multiple timepoints before and after primary and secondary immunization against yellow fever virus. Two biological replicates
of PBMCs and different cell subpopulations (indicated below each day of blood draw) were isolated at all timepoints. cDNA
TCR alpha and TCR beta libraries were sequenced on Illumina platform. B. The number of significantly expanded TCR alpha
and TCR beta clonotypes for both donors in comparison to day 0. C. Cumulative frequency of TCR alpha and beta clonotypes
of donor M1 after first (light blue and dark blue) and second immunization (dashed light blue and dark blue), and donor P30
(orange and yellow), which had a second immunization 30 years after the first. D. Cumulative frequency of CD4+ and CD8+
YF-responding clonotypes of donor M1 during the primary and secondary response to YFV17D.
after 18 months we observed in donor M1 (Fig. 1C), sug-
gesting that protection against the virus was maintained
even after 30 years.
Time traces show a strong response of several
clonotypes to booster vaccination
Our approach allows us to estimate the contribution
of individual clones to the total response. We already
showed that the overall response strength to secondary
immunization was an order of magnitude lower compared
to the primary response. However, several clones showed
remarkable expansion rates and peak frequencies, com-
parable to the ones observed in primary immunization.
Such clones were observed in both donors upon secondary
immunization after 18 months and 30 years (Fig. 2A and
B, Fig. S2). We traced each single clone during primary
and secondary response in donor M1. The concentration
of clonotypes prior to the booster immunization corre-
lated well (Pearson r=0.46 p < 0.0001) with their concen-
tration on day 45 after primary immunization (Fig. S3)
suggesting a uniform contraction rate for all clones re-
sulting in a half-life of 158±12.7 days for the YF-specific
T-cell subpopulation. Previously, Akondy et al. using
deuterium labeling of cells specific to the immunodomi-
nant epitope NS4B (as determined by a NS4B-multimer
binding assay) showed a very similar half-life of 123 days
[11].
It was previously reported that only 5-6% of YF-
responding clones are preserved as immune memory, with
the preferential recruitment of large clones [9]. By con-
trast, in our sample we could re-identify 96% of CD4+
and 88% of CD8+ clones that responded to the primary
immunization in at least one sample after the booster im-
munization. This suggests that practically all the diver-
sity of the responding repertoire is maintained in mem-
ory. The larger fraction of re-identified YF-responding
clones in comparison to previous work may be explained
by the sampling depth. Sequencing more T-cells will
lead to the re-identification of even more YF-responding
clonotypes.
We then wanted to characterize how these persistent
clonotypes responded to the booster vaccination. Inter-
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FIG. 2. Diversity of individual clonal trajectories in primary and secondary responses. A, B. Frequency of each
YF-responding clonotype as a function of time. Individual clones show remarkable expansion after the primary response (A, left
panel) and secondary response both 18 months (A, right panel) and 30 years (B) after the primary vaccination. The ten most
abundant (by peak frequency) CD4+ and CD8+ YF-responding clonotypes are shown for each vaccination. Color indicates
the time of the response peak for each clonotype: blue for a peak at day 5, pink at day 10, green at day 15 and purple at day
21. Despite overall heterogeneity in clonal traces, more clones peak at early timepoints during the secondary response. C, D.
PCA projection of individual time traces of clonal frequencies in donor M1. The frequency of each clonotype was normalized
by its maximum over time before PCA. Pink datapoints correspond to expanded clonotypes identified by edgeR. Circles and
crosses correspond to the labels of the two clusters identified by hierarchical clustering. Similar results are obtained with both
TCR alpha (C) and TCR beta (D) sequencing. E. Examples of time traces for two YF-responding (purple and green) and
one non-responding (blue) clonotypes in the TCR alpha repertoire (left), and their associated chain in TCR beta repertoire
(right). The similarity of the alpha and beta traces of the same clone allows for computational alpha-beta pairing prediction.
estingly, we found that the largest YF-specific CD8+
clones did not expand in response to the booster vaccine.
Instead, the most expanded clonotypes were rare prior to
the booster immunization (Fig. S4A). The situation was
different for CD4+ cells: both high and low-frequency
CD4+ clones expanded in response to the booster immu-
nization (Fig. S4B).
Identification of expanded clones by clustering of
individual clonal trajectories
To explore the heterogeneity of individual clonal tra-
jectories, we used principal component analysis (PCA).
For each timepoint after primary vaccination of donor M1
and previously described six donors from [10], we selected
the 1000 most abundant clonotypes. We then normalized
the time trace of each clonotype by its peak frequency,
and projected those traces onto two main directions of
variation using PCA (Fig. 2C, D).
5The PCA projection resulted in two distinct clusters
of time traces, corresponding to YF-responding and non-
YF-responding clonotypes identified by edgeR (Fig. S5).
This analysis demonstrates that such a clustering method
can identify expanding clones without the need of biolog-
ical replicates (Fig. S6) and can potentially reveal hidden
patterns in immune repertoire changes over time.
Computational alpha-beta TCR pairing using
individual clonal trajectories
The principal component analysis showed remarkably
similar patterns in both alpha (Fig. 2C) and beta (Fig.
2D) TCR repertoires. This concordance suggested the
possibility of pairing individual alpha and beta chains
together using the similarity of their clonal time traces,
as illustrated in Fig. 2E. We defined a similarity measure
for TCR alpha and TCR beta time traces, which takes
into account low count noise and potential differences in
expression between alpha and beta chains (see Methods).
We applied it to the top 1000 most abundant alpha and
beta clonotypes from day 15 after immunization.
As a benchmark, we performed two single-cell TCR
sequencing (scTCRseq) experiments using the 10x Ge-
nomics platform and obtained paired repertoires for sam-
ples of bulk T-cells (CD3+) and YF epitope-specific T-
cells (CD8+NS4B-dextramer+). Note that these two
samples are very different in their clonal time traces:
NS4B-specific clones show very active response dynam-
ics, expanding and contracting in the course of primary
and booster immunization, while the CD3+ T-cell sam-
ple corresponds to the most abundant clones in the reper-
toire, which are largely stable between timepoints.
For each alpha TCR from the bulk repertoire, we chose
five TCR beta sequences with the most similar clonal tra-
jectories and then tested for correct alpha-beta pairing
using the single-cell paired data. We showed that both
actively expanding or contracting as well as stable clono-
types could be paired with this approach. Out of the 62
NS4B-specific clonotypes sampled in the 10x Genomics
experiment, we were able to computationally identify 41
correct pairs from the bulk TCRseq data. Out of 26
CD3+ T-cell clonotypes, 20 were paired correctly.
TCR sequencing shows the transition of clonotypes
between memory subpopulations
Several studies have reported subsets of long-lived
memory YF-specific T-cells, whose concentration re-
mained stable for years [11, 14]. It was shown that these
long-lived memory cells are the progenies of effector cells,
which divide vigorously during the peak of the response
to the vaccine [11]. TCR sequences can be used as “bar-
codes” to measure transitions between different memory
subsets after YF immunization, defined by their surface
markers revealed by flow cytometry.
We isolated with FACS (see Fig. S7 for the gating
strategy) and sequenced TCR repertoires of 3 conven-
tional T-cell memory subpopulations: effector memory
(EM, CCR7-CD45RA-), effector memory re-expressing
CD45RA (EMRA, CCR7-CD45RA+), and central mem-
ory (CM, CCR7+CD45RA-) on days 0, 15, 45, and 18
months after the primary vaccination of donor M1 and on
days 0, 15, and 45 after the second vaccination of donor
P30. On day 45 we also isolated and sequenced the reper-
toire of the recently described Tscm (T-cell stem cell-like
memory) subset (CCR7+CD45RA+CD95+).
On day 0, the concentration of almost all YF-
responding clonotypes was too low to be detected in any
of these subpopulations. However, we were able to cal-
culate the distribution of YF-responding clonotypes be-
tween these phenotypes after immunization. The mem-
ory status of T-cell clones detected in the peripheral
blood was tightly correlated with their CD4/CD8 sta-
tus: CD4+ T-cell clones were distributed between EM
and CM, while CD8+ T-cell clones were found in EM
and EMRA (Fig. 3A). This difference held not only for
YF clones but for the peripheral blood T-cell repertoire
in general, in agreement with previous studies [20, 21].
While for most CD8+ clonotypes in the total repertoire
EM/EMRA phenotypes were stable between day 15 and
day 45 (Fig. 3B, and Fig. S8A, C), the distribution
of CD8+ YF-responding clones between memory subsets
was significantly shifted towards the EMRA phenotype
(Fig. 3C). This shift results from two processes: the
rapid decay of EM cells (Fig. S8B) and the phenotype
switch from EM to EMRA (Fig. S8D). Almost all YF-
responding CD8+ clones detected 18 months after the
first immunization corresponded to the EMRA pheno-
type (among 71 clones found in more than 3 copies in
bulk repertoire at day 0 before second vaccination, 41
were found only in the EMRA subset, 4 only in EM, and
6 in both). For CD4+ T-cells, we did not observe any
trend in phenotype switching between days 15 and 45 af-
ter the vaccination. We hypothesize that switching from
EM to CM phenotype was masked due to homing of CM
cells to lymphoid organs, defined by the expression of the
CCR7 chemokine receptor.
The response to a single immunodominant epitope
can contribute to up to 60% of the total response
It was previously shown that in HLA-A02 donors the
NS4B214−222 LLWNGPMAV immunodominant epitope
elicits the strongest CD8+ T-cell response [3, 5, 7, 15].
Using an HLA-A02-pMHC-dextramer, we isolated NS4B-
specific CD8+ T-cells from both donors (Fig. S9) and ap-
plied TCR sequencing to get their unpaired TCR alpha
and TCR beta repertoires. We obtained ≈2100 alpha
and ≈2000 beta functional receptor chains, one of the
largest datasets for TCRs with a single specificity. YF-
responding clonotypes identified by edgeR as expanded
between timepoints are not restricted to any particular
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clones between memory subpopulations for a set of CD4+ (left panel) and CD8+ (right panel) clonotypes for donors M1 (top)
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with 30 or more Unique Molecular Identifiers (see Methods) in bulk repertoires on day 45 were used for the analysis.
YF epitope and represent the repertoire targeted towards
many different peptides presented by different HLA alle-
les. This allows us to quantify the relative contribution of
NS4B-specific T-cells to the total anti-YF response. At
the peak of the response, approximately 24% of all YF-
responding CD8+ T-cells were specific to NS4B in the
donor vaccinated 30 years ago (P30), and up to 60% in
the first time vaccinee (M1) (Fig. 4A). However, NS4B-
specific clonotypes could not be distinguished from other
YF-responding clonotypes from their time traces alone,
as they both responded with similar dynamics (Fig. S10).
Sequence analysis and structural modeling of
NS4B-specific TCRs reveals two motifs with distinct
peptide binding modes
We next asked whether there are distinct features in
the sequence of NS4B-specific TCRs, which might ex-
plain the immunodominance of this epitope. Figures 4B
and C show sequence similarity networks for TCR alpha
and TCR beta chains of NS4B-specific clonotypes. The
TCR alpha repertoire shows biased V-usage and com-
plementarity determining region 3 (CDR3) lengths (Fig.
4D). TRAV12-2, TRAV12-1, TRAV27, and TRAV17
gene usage were significantly enriched in the NS4B-
specific TCRs (exact Fisher test, Benjamini Hochberg
adjusted p < 0.001), with more than 45 percent of the
clonotypes expressing TRAV12-2, in comparison to just
4.5% of TRAV12-2 in the total CD8+ TCR repertoire.
Beta chains formed several distinct clusters of highly sim-
ilar sequences, with significant but less marked V-usage
biases towards TRBV9, TRBV15, and TRBV6-1/2, as
well as some bias in the length distribution (Fig. 4E).
Almost 37% of NS4B-specific clonotypes used TRBJ2-7.
We next asked how these clusters of highly similar se-
quences in the alpha and beta NS4B-specific repertoires
corresponded to each other. Prior to booster immu-
nization, we isolated NS4B-specific T-cells from donor
M1 (Fig. S11) and performed single-cell RNA sequenc-
ing (scRNAseq) and single-cell paired TCR sequencing
(scTCRseq). We collected data from 3500 cells corre-
sponding to 164 clonotypes (see Methods). Fig. 4F
shows a joint similarity network for TCR alpha and TCR
beta chains, with both intra-chain sequence similarity
and inter-chain pairings. Alpha-beta pairing seemed to
be mostly random, with some exceptions: for instance,
specific TCRs using the most dominant TRAV12-2 alpha
motif were paired with many different beta chains with a
broad usage of V-segments (Fig. 4G and Fig. S12), but
with a restricted CDR3β length of 13–14 amino acids.
TCRs using TRAV27 and TRBV9 segments were also
preferentially paired with one another (Fig. S13). Clus-
tering of paired sequences using the TCRdist measure
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and by TRAV27 segment paired preferentially with TRBV9 (pink).
(Fig. S14) resulted in two large clusters corresponding
to these two major motifs with conserved V-usage.
The preferential usage of the TRAV12 family was re-
ported before for TCRs responsive to the NS4B epitope
[22, 23]. It was speculated [22], that the CDR1α of this
V-segment forms contacts with the peptide. To test this
hypothesis, we modeled the 3D structures of clonotypes
from scTCRseq using the Repertoire Builder server [18]
and then docked the resulting model structures using
RosettaDock [24] to the HLA-A02 pMHC complex struc-
ture, recently solved using X-ray crystallography [22],
see Methods for details. Models of TCR-pMHC com-
plexes showed that the TRAV12-2 TCRs formed more
contacts with the peptide using CDR1α loops, and fewer
contacts with CDR3α loops, in comparison to TRAV27
TCRs (Fig. S15). Interestingly, CDR3α sequences of
TRAV12-2 TCRs were very similar to the ones observed
in the repertoire of the same donor prior to the immu-
nization, suggesting absence of epitope-driven selection
of the CDR3α of these TCRs (Fig. S16). Based on these
results, we hypothesize that TCRs using TRAV12 and
TRAV27 motifs represent two independent and distinct
solutions to the binding of the NS4B epitope.
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FIG. 5. Phenotypic diversity of NS4B-specific cells 18 months after yellow fever immunization. A. 2D t-SNE
visualization of unsupervised clustering (Seurat analysis) of RNAseq data based on 2000 most variable genes shows three
distinct clusters of NS4B-specific cells. B. The heatmap of top 15 significantly enriched genes of single cells in clusters 1 and
2 defined by the MAST algorithm. The panel above the heatmap identifies the cluster identity of the cells. C. Gaussian
kernel density estimate for the relative fraction of cells belonging to cluster 1 for each clonotype. Blue distribution shows the
theoretical prediction under the null hypothesis: clonotype labels were shuffled between cells (1000 permutations). The observed
distribution is flatter than the theoretical one, indicating the presence of clonotypes with either a minority or a majority of
cells belonging to cluster 1 (χ2-test with MC-estimated p-value=0.0005).
scRNAseq of NS4B-specific T-cells reveals two
distinct cytotoxic phenotypes
Next we used the scRNAseq gene expression data to in-
vestigate the phenotype of specific T-cells in finer detail.
While almost all NS4B-specific clonotypes 18 months af-
ter vaccination belonged to the conventional EMRA sub-
set, scRNAseq revealed huge heterogeneity of gene ex-
pression inside this population. Unsupervised clustering
by Seurat 3.0 software [25, 26] (see Methods) revealed
three sub-phenotypes of NS4B-specific cells (Fig. 5A).
Overall we found 166 genes that were differentially ex-
pressed according to the MAST algorithm [27] between
these clusters (Fig. 5B). Cells from cluster 1 showed high
expression of cytotoxicity related genes GZMB, GNLY,
GZMH, NKG7, PRF1, CX3CR1, SPON2, KLRD1, Ho-
bit and T-bet transcription factors (Fig. S17). The com-
bination of these genes also suggests that this cytotoxicity
is mediated by the perforin pathway. The second cluster
of cells is enriched in genes such as CCR7, TCF7, SELL,
JUNB, LEF1, and especially IL7R which are essential
for long-term survival and maintenance of memory T-
cells (Fig. S18) [28–32]. However, these cells also express
unique markers related to cytotoxicity: GZMK, LTB as
well as KLRG1, KLRB1, T-bet, and GZMH, albeit at
lower levels than cells in cluster 1.
Very similar clusters of genes were found in single-cell
RNAseq analysis of CD4-cytotoxic lymphocytes EMRA
cells [33]. The expression pattern of granzymes and
killer-like receptors in our clusters suggests that cells in
cluster 2 may be the precursors of cells in cluster 1. The
expression of GZMK (enriched in cluster 2) was shown
to be prevalent in early memory stages [34, 35], while
high levels of GZMB, GZMH, KLRB1, KLRG1, and AD-
GRG1 (enriched in cluster 1) are associated with more
terminally differentiated memory cells with higher cyto-
toxic potential [36, 37]. Interestingly, cluster 2 has lower
expression of genes encoding ribosomal proteins, which
were recently reported to be a feature of memory pre-
cursor cells [38]. The transition of cells between the two
clusters is also supported by the existence of cluster 3,
which shows intermediate gene expression of cluster 1
and 2 markers, and thus may represent cells gradually
changing phenotype.
For each cell from the scRNAseq experiment, we ob-
tained matched scTCRseq results. We wondered whether
9the TCR clonotype influenced cell gene expression pro-
file. Interestingly, the distribution of clonotypes between
clusters was not random (χ2-test with MC-estimated p-
value=0.0005): some clonotypes showed a clear prefer-
ence for one of the phenotypes (Fig. 5C). To match
single-cell gene expression data with measurements of
clonotype concentrations obtained with TCRseq, we av-
eraged mRNA counts over the all cells of the same clono-
type, and repeated the differential gene expression analy-
sis (see Methods). We obtained two clusters of clonotypes
with the same enriched genes (Fig. S19) as observed for
clusters of single cells (Fig. 5B), confirming the associa-
tion of phenotype and clonotype. Clonotypes from both
clusters expanded following the second immunization, in-
dicating that both phenotypes are capable of response.
Clonotypes associated to cluster 1 had larger frequencies
both on day 45 after the first vaccination (Fig. S20A),
and 18 months later before the booster shot (Fig. S20B),
than clonotypes associated to cluster 2. This result sug-
gests that even for T-cells recognizing the same epitope,
particular clones are linked to particular memory pheno-
type.
DISCUSSION
In this study, we applied high-throughput sequencing
of TCR alpha and TCR beta repertoires to track T-cell
immune response to primary and secondary immuniza-
tion with yellow fever vaccine. This approach does not
require previous knowledge of TCR specificity and thus
allows us to quantify and compare the response of indi-
vidual T-cell clones recognizing different epitopes on the
same scale.
We found that up to 60% of all responding CD8+
T-cells were specific to a single immunodominant pep-
tide. Several studies reported high precursor frequency
of T-cells reactive to this epitope [22, 23]. Bovay et
al. recently suggested that recognition of antigenic pep-
tide through the germline-encoded CDR1 loop of the
TRAV12 segment is one of the main reasons for high
precursor frequency [22]. This hypothesis is supported
by our TCR structural modeling and TCR-pMHC dock-
ing simulations, as well as by the analysis of the NS4B-
specific T-cell repertoire. We also identified an addi-
tional motif defined by TRAV27+TRBV9+ TCRs. It
will be interesting to investigate if these two motifs dif-
fer in binding affinity or are susceptible to potential es-
cape mutations that can appear in the antigenic peptide.
Another question is how diverse is the level of clonal re-
sponse to the YF vaccine in HLA-A02 negative donors,
and what fraction of the response is directed towards the
most immunodominant epitopes in the context of other
HLA types.
Most previous studies focused on TCR beta reper-
toires, partially because the diversity of TCR beta is
higher, making it a better marker for clonal tracking [39].
We found that TCR alpha may be used for clonal track-
ing as well, giving almost the same results as TCR beta
in terms of the number of expanding clonotypes and their
cumulative fractions on different timepoints. In the par-
ticular case of the response of HLA-A02 donors to the
YF vaccine, the TCR alpha repertoire turned out to be
even more informative, as T-cells responding to the im-
munodominant epitope predominantly use certain TRAV
segments.
One of the major limitations of bulk TCR sequenc-
ing is that the resulting repertoires are unpaired, while
TCR specificity in most cases is defined by the combina-
tion of alpha and beta chains. We show that the simul-
taneous sequencing of bulk alpha and beta repertoires
performed on many timepoints allows us to make pre-
dictions on alpha-beta pairing. Even with the rise of
single-cell sequencing, this method might still be of in-
terest since most available single-cell platforms can only
analyze limited numbers of 104-105 cells. In addition,
these experiments are still expensive in comparison to
the bulk TCR sequencing, which enables the profiling of
millions of lymphocytes more cheaply.
We found that ≈ 90% clonotypes responding to pri-
mary immunization were present in peripheral blood 18
months after immunization. Recently, Akondy et al.
showed using deuterium cell labeling that long-survived
memory cells have a history of intense clonal expansion,
and thus are likely to differentiate from effector cells af-
ter response [11]. This explains both the high remain-
ing diversity of YF-responding clonotypes and a propor-
tional decrease of these clonotypes between primary and
booster immunizations.
Interestingly, we observed a very different response of
CD4+ and CD8+ memory cells to the booster vacci-
nation. It may be explained by differences in antigen
presentation mechanisms: CD4+ T-cells may be acti-
vated well by antigen presenting cells phagocyting neu-
tralized viral particles and presenting exogenous peptides
on MHC-II complexes, while CD8+ memory cells can be
more efficiently triggered by a productive viral infection
resulting in the presentation of endogenously translated
viral proteins on MHC-I. It was previously shown that
the magnitude CD8 response depends on the viral load
[4].
It will be interesting to perform a similar study in
donors vaccinated with YF backbone chimeric vaccines,
where genes from other viruses substitute some of the
YFV17D genes. It was shown that preexisting anti-YF
immunity [40] does not affect the formation of neutraliz-
ing antibodies to the novel virus. This finding suggests
that not only efficient reactivation of existing CD4 mem-
ory but also the formation of CD4 responses to novel
epitopes is possible during the booster with slightly dif-
ferent antigen.
We found that, while the overall secondary response
to the vaccine was much smaller both in terms of clonal
diversity and cumulative frequency, a few clones still un-
dergo strong clonal expansion. This may be indirect ev-
idence for the programmed proliferation hypothesis [41]
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according to which a single encounter of a TCR with an
antigen triggers several rounds of T-cell division. It was
shown that the virus is undetectable in the peripheral
blood after booster vaccination [42], meaning that the
amount of available antigen is much lower, and so is the
number of encounters and responding clonotypes.
The transition between EM and EMRA phenotypes in
CD8+ clones responding to yellow fever vaccine was pre-
viously measured using flow cytometry [14, 15]. Here we
confirm these reports with high-throughput sequencing,
using TCR as a barcode to mark cells of the same clonal
lineage. Furthermore, we identified two distinct cytotoxic
phenotypes in NS4B-specific T-cells 18 months after pri-
mary immunization. It is not clear why the distribution
of clonotypes between two these phenotypes was biased.
Since we performed scRNAseq of clonotypes specific to
the single antigen, these differences might be either the
consequence of different TCR affinity or some phenotypic
heterogeneity present in the precursor cells. Additional
experiments at later timepoints would be required to es-
timate the longevity of these clonotypes.
To summarize, we show that vaccination with YFV17D
leads to the recruitment of a diverse repertoire of T-cells,
which is then available as immune memory for the sec-
ondary response years after the immunization. Even T-
cells with the same epitope specificity show several dis-
tinct motifs in TCR and have different memory pheno-
types. Such heterogeneity of cells might be crucial for in-
dividual immune response robustness, underlying cross-
reactive responses to similar viruses, and the possibil-
ity to escape mutants, which could be tested directly in
future studies. However, this diverse T-cell response is
strongly focused on single HLA-A02 restricted epitope.
An interesting question is how many distinct foci of re-
sponse exist in the human population with a variety
of HLA-types; and how this diversity of individual re-
sponses contribute to the defense from the infection at
the population level. Systematic studies of donors with
different genetic backgrounds and corresponding immun-
odominant epitope-specific repertoires will be able to ad-
dress this question.
METHODS
Donors and blood samples
Blood samples were collected from two healthy donors
(M1 male age 26, and P30 male age 39) on multiple time-
points before and after immunization with YFV17D vac-
cine. All donors gave written informed consent to par-
ticipate in the study under the declaration of Helsinki.
The blood was collected with informed consent in a cer-
tified diagnostics laboratory. The study was approved by
the institutional review board (IRB) of Pirogov Russian
National Research Medical University. HLA haplotypes
of donors (Table S1) were determined by in-house RNA-
based amplification and sequencing method.
Isolation of T-cell subpopulations
We isolated PBMCs from the blood using standard
Ficoll-Paque protocol. CD4 and CD8 fractions were
isolated with CD4/CD8 Positive Selection Dynabeads
Kits according to the manufacturer’s protocol. For
isolation of memory subsets, we stained PBMCs with
the mix of antibodies: anti-CD3-FITC (UCHT1, eBio-
science), anti-CD45RA-eFluor450 (HI100, Invitrogen),
anti-CCR7-AlexaFluor647 (3D12, BD Pharmingen),
anti-CD95-PE (DK2, eBioscience). Four subsets of
cells were sorted into RLT buffer (Qiagen) on BD
FACS Aria III: EM (CD3+CD45RA-CCR7-), EMRA
(CD3+CD45RA+CCR7-), CM (CD3+CD45RA-
CCR7+), Tscm (CD3+CD45RA+CCR7+CD95+).
HLA-A02 dextramer loaded with the NS4B214−222
peptide (LLWNGPMAV) from YFV17D (Immudex) was
used for epitope-specific T-cells isolation. Cells were
stained with NS4B-dextramer-PE, anti-CD3-eFluor450
(UCHT1, Invitrogen), and anti-CD8-FITC (SK1, Invit-
rogen) according to the manufacturer’s protocol. RNA
was isolated using standard TriZol protocol (for bulk
PBMCs, CD4 and CD8, NS4B-specific and negative
fractions) or RNAeasy Micro Kit (Qiagen) (for memory
subsets). The amount of RNA was measured on Qubit
2.0 (Invitrogen).
Sample preparation for the single-cell gene
expression and immune profiling
For 10x Genomics single-cell gene expression and im-
mune profiling, we used PBMCs isolated from 60 ml
of blood of donor M1 before the second immunization.
PBMCs were stained with NS4B-dextramer-PE (Im-
mudex) according to the manufacturer’s protocol. Addi-
tionally, cells were stained with anti-CD3-eFluor450 (In-
vitrogen), and anti-CD8-FITC (Invitrogen). Previous to
FACS sorting procedure, we used propidium-iodide to
mark dead cells. As the NS4B-specific cell frequency was
very low (Fig. S11A), we used anti-PE Ultra-pure Mi-
croBeads (Miltenyi) for the enrichment. In brief, every
milliard of PBMCs was incubated with 10 µl of magnetic
beads for 15 minutes on ice. After a washing step with
PBS 5% FCS, the cell suspension was applied on MS
MACS Column (Miltenyi). Columns were washed three
times with PBS 5% FCS and stained with propidium-
iodide just before the FACS (FACS Aria II). This pro-
cedure resulted in a dramatic increase of NS4B-specific
cell frequency in the sample (Fig. S11B) and accordingly
lead to reduced FACS procedure time. For single-cell
immune profiling of bulk T-cell clonotypes from PBMCs,
we stained the cells with anti-CD3-eFluor450 (Invitro-
gen) and propidium-iodide, thus selecting CD3 positive
cells. Approximately 10,000 CD3+ cells were used for
10x Genomics VDJ T-cell receptor enrichment protocol.
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High throughput T-cell repertoire sequencing
Libraries of TCR alpha and TCR beta chains were
prepared as previously described [43]. In brief, isolated
RNA was used for cDNA synthesis with 5’RACE tem-
plate switch technology to introduce universal primer
binding site and Unique Molecular Identifiers (UMI) at
the 5’ end of RNA molecules. Primers complementary to
both TCR alpha and TCR beta constant segments were
used for cDNA synthesis initiation. cDNA was amplified
in two subsequent PCR steps. During the second PCR
step, sample barcodes and sequence adapters were intro-
duced to the libraries. Libraries for the fractions with low
amount of cells (Table S2) were prepared using SMART-
Seq v4 Ultra Low Input RNA kit (TakaraBio). Libraries
were sequenced on Illumina platform HiSeq 2500 with
2×100 bp sequencing length or NovaSeq 2×150 bp se-
quencing length. Parallel single-cell alpha/beta TCR
and 5’ gene expression sequencing was performed using
10x Genomics Kits (Chromium Single Cell A Chip Kit,
Chromium Next GEM Single Cell 5’ Library and Gel
Bead Kit, Chromium Single Cell V(D)J Enrichment Kit,
Human T Cell, Chromium Single Cell 5’ Library Con-
struction Kit, Chromium i7 Multiplex Kit) according to
the manufacturer’s protocol. Libraries were sequenced on
Illumina platform HiSeq 3000 with 2×150 bp sequencing
length.
Repertoire data analysis
Raw data preprocessing. Raw repertoire sequenc-
ing data were preprocessed as described in [43]. Briefly,
sequencing reads were demultiplexed and clustered by
UMI with MIGEC software [44]. The alignment of ge-
nomic templates to the resulting consensus sequences was
performed with MiXCR [45]. Raw sequencing data ob-
tained from RNAseq experiments were analyzed directly
with MiXCR using default RNAseq analysis pipeline.
Identification of changed clonotypes by edgeR.
To identify TCR alpha and TCR beta clonotypes that
significantly expand after YF vaccination, we used the
edgeR package [46] as previously described [10]. In brief,
for each timepoint, we used two biological replicates of
bulk PBMC. TMM-normalization and trended dispersion
estimates were performed according to edgeR manual.
We used an exact test based on the quantile-adjusted con-
ditional likelihood (qCML) to identify clonotypes signif-
icantly expanded between pairs of timepoints. A clono-
type was considered YF-responding if its log2-fold change
estimate log2FC> 5 between any pairs of timepoints from
0 to the peak of the primary response (day 15). The p-
value threshold for calling YF-responding clonotypes was
set to 0.01 after multiple testing correction. The list of
YF-responding clonotypes identified in alpha and beta
TCR repertoires of donor M1 are in Table S3 and Table
S4 respectively. The list of YF-responding clonotypes
identified in alpha and beta TCR repertoires of donor
P30 are in Table S5 and Table S6 respectively. CD4/CD8
in silico phenotyping was performed as suggested before
[10]: for each clone from bulk PBMC repertoire we assign
CD4 phenotype if it is more abundant in the sequenced
CD4 repertoire and vice versa.
Identification of YF-responding clonotypes by
Principal Component Analysis (PCA). We chose
clonotypes that appeared in the top 1000 most abundant
clonotypes at any timepoint after primary immunization.
For these clonotypes, we made matrices of frequencies on
all timepoints after primary immunization. Before apply-
ing PCA to these matrices, each value was normalized
by dividing on maximum frequency for this clonotype.
For cluster identification, we used hierarchical cluster-
ing with average linkage on euclidean distances between
clonotypes. The number of clusters was set to 2. This
analysis was performed for both alpha and beta chains
of donor M1. For the twin donors [10], only replicate F1
was used for changed clones identification.
Memory transition analysis. For this analysis, we
used clonotypes that had at least 30 UMIs at day 45 after
primary vaccination. The clonotype frequency in mem-
ory subset is multiplied by the number of cells obtained
by FACS on this timepoint for this subset. Then adjusted
frequencies are normalized across all subsets to get a par-
tition of each TCR clonotypes across subsets. Obtained
partitions were multiplied by the frequency of a clono-
type in bulk at this timepoint to get the concentration
of clonotypes with a particular memory phenotype in the
bulk repertoire.
Computational decontamination of NS4B-
specific repertoire. Since FACS sorting is not pre-
cise, TCR repertoires of the population of interest of-
ten contains abundant clonotypes from the bulk popu-
lation. To obtain a list of NS4B-specific TCRs we took
clonotypes that were enriched (at least 10 times) in the
A02-NS4B-dextramer positive fraction compared to A02-
NS4B-dextramer negative fraction. We also discarded
TCR clonotypes that were more abundant in CD4 than
CD8 subpopulation on day 0 (as only CD8 cells should
bind to A02 which is a MHC I allele). See Tables S7-S10
for resulting list of NS4B-specific alpha and beta clono-
types for both donors.
Computational pairing of TCR alpha and TCR beta
from bulk repertoires
For pair of clonal time traces we used a Euclidian dis-
tance between transformed frequencies:
D(Cα, Cβ) =
√∑
i
(t(Cα,i)− t(Cβ,i))
2
,
where Cα,i and Cβ,i are the concentrations of an α and
a β chain on the i-th timepoint. The transformation t of
clone concentration C was chosen to address the overdis-
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persion of frequencies at large concentrations (see [10]):
t(Ci) = log10 (
√
a+ bCi +
√
bCi),
where a = 4.26× 10−6 and b = 3.09× 10−3. To address
possible systematic bias in expression between α and β
chains in a clonotype, we introduce a log-fold shift λ in
a trajectory with a quadratic penalty (µ=0.1):
Ds(Cα, Cβ) = min
λ
(D(Cα, 10
λCβ) + µλ
2).
We calculated Ds distances between each pair of α and
β clonotypes out of the 1000 most abundant ones in the
bulk repertoires on day 15 post-vaccination. For each α
clonotype, we picked the 5 closest β clonotypes as candi-
date pairings.
Paired single-cell TCR sequencing
To investigate TCR chains pairing in YF-specific
clonotypes, we performed single-cell immune profiling
with 10x Genomics protocol. The analysis of the data
with Cell Ranger 2.2.0 (10x Genomics) with default pa-
rameters resulted in 3244 cells corresponding to 986
clones. Many of these clones had multiple TRA/TRB
chains and are likely to represent multimers of cells (Fig.
S21). For further analysis, we chose only high-confident
clones that had one TRA and one TRB chain and were
present more than twice in the data. This procedure re-
sulted in the list of ≈ 2000 cells corresponding to 164
TCR alpha/beta clones (Table S11).
TCR-pMHC complex modeling
Models for each paired alpha-beta TCRs from 10x
Genomics data were constructed using the RepBuilder
server (https://sysimm.org/rep_builder/) [18] , and
then docked to HLA-A02-LLWNGPMAV complex us-
ing rosettaDock2 (https://www.rosettacommons.org/
software) routine [24]. 152 TCRs passed the model-
ing step. For each TCR we obtained 1000 decoys in
docking simulations. The thirty best decoys (by inter-
face score) were used to calculate a contact map with
the bio3d R package [47]. It was previously shown [19],
that some docking decoys exhibit binding modes which
are not found in natural TCRs. In the analysis, we only
used decoys in which the root mean squared deviation
between the centers of mass of the alpha and beta chains
in the decoys, and the centers of mass of these chains
in at least one published HLA-A02-TCR complex from
ATLAS database [48], were less than 4 A˚. The num-
ber of contacts to the peptide was averaged over decoys
that passed the threshold. Only clonotypes with > 5 of
resulting filtered decoys were used for the analysis (see
Fig. S15).
Single cell gene expression analysis
For single-cell gene expression analysis, we pre-
processed the data with Cell Ranger 2.2.0 (10x Ge-
nomics). We used GRCh38-1.2.0 reference genome for
the gene alignment. The resulting gene count matrix was
analyzed with Seurat 3.0 package [25, 26]. Cells that had
fewer than 200 features detected were filtered out. We
also filtered out features that were present in fewer than
3 cells and genes of TCR receptors (e.g., TRAV, TRAJ,
TRBV, TRBJ ), as they are the source of unwanted vari-
ation in the data (Fig. S22). Then a standard data pre-
processing was performed to remove low-quality cells and
cells multiplets. We filtered out cells that had more than
2700 features or more than 8% of mitochondrial genes
(Fig. S23). Feature expression measurements for each
cell were normalized using default log-normalization in
the Seurat package. Following the manual’s suggestion,
the 2000 most variable features were selected for further
analysis. Prior to dimensionality reduction, data were
scaled so that the mean expression was 1 and the vari-
ance equals to 1. The first 10 dimensions of PCA were
used for cluster identification with the resolution param-
eter set to 0.4. To identify differentially expressed genes
between clusters we used the MAST algorithm [27] im-
plemented in the Seurat package. We only tested genes
that were present in more than 25% of cells in any group
and that had at least a 0.25 log fold difference between
the two groups of cells. The resulting list of differentially
expressed genes is reported in Table S12.
We performed a similar analysis to identify differen-
tially expressed genes between clonotypes (rather than
individual cells). We created a matrix containing the
mean gene expressions over cells within each clonotype,
and treated it like normal single-cell results. In this case,
we did not filter multiplet cells (with a high number of
features and a high percentage of mitochondrial genes),
as all our “cells” were indeed computational multimers.
The rest of the analysis was performed in the same way.
The list of differentially expressed genes between clus-
ters of clonotypes is reported in Table S13. To check the
results we shuffled cell barcodes between the clonotypes
and repeated the analysis. All cells ended up in a single
cluster for this random control.
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FIG. S1. Number of significantly expanded TCR beta clonotypes between day 0 and 15 identified by the edgeR
software. Donor revaccinated 30 years after the primary immunization has significantly fewer expanded clonotypes then any
primary vaccinee.
FIG. S2. Individual clonal trajectories of all YF-responding clonotypes. Frequency of each YF-responding clonotype
as a function of time. Individual clones show remarkable expansion after the primary response (A, left panel) and secondary
response both 18 months (A, right panel) and 30 years (B.) after the primary vaccination. Color indicates the time of the
response peak for each clonotype: blue for a peak at day 5, pink at day 10, green at day 15 and purple at day 21.
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FIG. S3. Decay of YF-responding clonotypes between primary and secondary immunization. Frequencies of YF-
responding clones on day 45 of the primary immunization of donor M1 versus their frequencies 18 months later, before the
second immunization). Diagonal line shows identity.
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FIG. S4. Frequencies of CD4 (A) and CD8 (B) clonotypes having responded to the primary YFV17D immu-
nization in bulk before (x-axis) versus at the peak of the response to booster immunization (y-axis). Diagonal
line shows identity.
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FIG. S5. Dynamics of YF-responding clonotypes after primary vaccination (data from Pogorelyy et al. 2018).
The cumulative frequency of YF-responding clonotypes defined as significantly expanded by edgeR is shown in blue. The
green line indicates the cumulative frequency of responding clonotypes identified by hierarchical clustering of individual clonal
trajectories. For the clustering procedure, only frequencies of biological replicate 1 of the bulk repertoire were used.
FIG. S6. YF-responding clones identified using hierarchical clustering of clonal time traces without biological
replicates. The plot shows two first principal components (x and y-axis) of the matrix, where rows are clonotypes and
columns are normalized frequencies of these clonotypes on timepoints before and after primary immunization of donor M1. The
frequency of each clonotype was normalized by its peak concentration. Pink color shows expanded clonotypes identified with
edgeR. Two clusters (circles and crosses) were identified using hierarchical clustering. Similar results were obtained for both
TCR alpha (A) and TCR beta (B) sequencing.
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FIG. S7. Gating strategy for memory subpopulation. Central memory (CM) cells were defined as CD3+CCR7+CD45RA-
. Effector memory (EM) cells were CD3+CCR7-CD45RA-. Terminally differentiated effector memory (EMRA) cells were
CD3+CCR7-CD45RA+. Stem-cell like memory (Tscm) cells were CD3+CCR7+CD45RA+CD95+.
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FIG. S8. EM-EMRA transition and decay between day 15 and day 45. We plot concentrations of EM (A, B)
and EMRA (C, D) cells of each clone with > 30 UMI on day 45 in the bulk repertoire for non-YF-responding (A, C) and
YF-responding (B, D) on day 15 (x-axis) versus day 45 (y-axis). Diagonal line shows identity.
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FIG. S9. Isolation of NS4B-specific T-cells of donor M1 (A) and donor P30 (B) on different timepoints after
YF vaccination.
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FIG. S10. Dynamics of immunodominant response and other responses. Total frequency of YF-responding NS4B-
dextramer positive (solid line) and other YF-responding CD8 clonotypes (dashed line) is plotted on different timepoints after
immunization. All clonotypes are called YF-responding using edgeR.
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FIG. S11. Number of NS4B-dextramer-positive cells before (A) and after (B) enrichment on the magnetic
beads. FACS was performed on donor M1 before the second immunization.
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FIG. S12. TRAV-TRBV pairing in NS4B-dextramer-positive cells. Each dot shows TRAV-TRBV combination. The
observed number of clonotypes using this combination in TCR is plotted against the number expected under random pairing
from TRAV and TRBV frequencies. TRBV9 is expected to form more pairs with TRAV12-2 but pairs with TRAV27 instead,
suggesting the existence of selective pressure on the choice of both chains.
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FIG. S13. Pairings of J-segments and V-segments of TCR alpha (left) to V-segments and J-segments of TCR
beta (right) in scTCRseq of NS4B-specific T-cells. The height of each box is proportional to the number of unique clones
with a given gene segment. The width of the ribbons is proportional to the frequency of segment combinations. NS4B-specific
TCRs have two main binding modes, defined by the TRAV12 segment family paired to almost any TRBV (blue) and by the
TRAV27 segment paired preferentially with TRBV9 (pink). Other combinations are shown in green.
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FIG. S14. Results of TCRdist hierarchical clustering of paired scTCR repertoire of NS4B-specific cells. The two
largest branches indicated with arrows correspond to TRAV12-2 and TRAV27-TRBV9 motifs.
A
B
FIG. S15. Average number of contacts to the LLWNGPMAV peptide in complementary determining regions
of TCR alpha (A) and TCR beta (B) chains. TCRs with TRAV12 segment (green and pink) have significantly more
contacts ( Mann Whitney U-test p-value = 0.00015) in CDR1α than TCRs with TRAV27 (purple). On the other hand TCRs
with TRAV27 have more contacts in CDR3α than TRAV12-2 TCRs ( Mann Whitney U-test p-value = 0.009). No significant
difference in the number of contacts was observed for these binding modes in CDRs of the TCR beta chain.
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FIG. S16. Frequency of amino acids in CDR3s of clones with TRAV12-2 and TRAV27 V-segments in dextramer-
sorted NS4B-specific clonotypes and bulk CD8 clonotypes prior to the vaccination. For TRAV12-2 motif frequency
distribution for TRAV12-2 is close to observed in bulk, suggesting absence of strong selection for certain amino acids in certain
positions.
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FIG. S17. Expression of 15 genes most characteristic of cluster 1 in cells corresponding to clusters 1 (pink), 2
(green) and 3 (blue). Cluster 3 has the intermediate phenotype.
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FIG. S18. Expression of 15 genes most characteristic of cluster 2 in cells corresponding to clusters 1 (pink), 2
(green) and 3 (blue). Cluster 3 has the intermediate phenotype.
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FIG. S19. Genes differentially expressed between clonotypes. Gene expression in each cell was averaged over the clono-
types before differential gene expression analysis. Unsupervised clustering shows 2 clusters with very similar gene expression
to clusters 1 and 2 observed on scRNAseq of individual cells (Fig. 5B).
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FIG. S20. Frequency of clonotypes corresponding to cluster 1 and 2, after primary immunization (A), and 18
months later before the booster vaccination (B). Clonotypes associated to cluster 1 are significantly more abundant in
both these timepoints (Mann Whitney U-test A: p-value = 0.0003; B: p-value = 0.02447 ).
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FIG. S21. Proportion of cells (A) and clonotypes (B) in single-cell TCR sequencing data carrying different
numbers of TCR alpha and TCR beta chains.
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FIG. S22. Most variable genes in the dataset before (A) and after (B) the filtration of TCR related genes. TCR
related genes were the source of unwanted variation in single-cell gene expression analysis and were removed from the data.
2.5
5.0
7.5
10.0
2500 5000 7500 10000 12500
nCount_RNA
pe
rc
en
t.m
t
Identity
10X_tet
−0.15
500
1000
1500
2000
2500
3000
2500 5000 7500 10000 12500
nCount_RNA
nF
ea
tu
re
_R
NA
Identity
10X_tet
0.94A B
FIG. S23. Visualization of quality control metrics in the single-cell gene expression experiment. The relationship
between the number of RNAs inside the cell (x-axis) and the percentage of mitochondrial genes (y-axis) is shown on the left.
The relationship between the number of RNAs inside the cell (x-axis) and the number of genes (y-axis) is shown on the right.
Cells that had more than 8% of mitochondrial genes or more than 2700 total number of genes were discarded from further
analysis.
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TABLE S1. HLA-typing results for donors M1 and P30
Locus M1 P30
A 02:01:01/24:02:01 02:01:01/31:01:02
B 15:01:01/39:01:01 35:01:01/48:01:01
C 03:04:01/12:03:01 04:01:01/08:01:01
DQB1 02:01:01/03:02:01 03:01:01/03:01:01
DRB1 03:01:01/04:01:01 11:01:01/12:01:01
DRB3 02:02:01 01:01:02/02:02:01
DRB4 01:03:01 -
